BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Micale V, Di Bartolomeo M, Di Martino S, Stark T, Dell'Osso B, Drago F, D'Addario C. Are the epigenetic changes predictive of therapeutic efficacy for psychiatric disorders? A translational approach towards novel drug targets. Pharmacol Ther 2023;241:108279. [PMID: 36103902 DOI: 10.1016/j.pharmthera.2022.108279] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Wawrzczak-bargieła A, Bilecki W, Maćkowiak M. Epigenetic Targets in Schizophrenia Development and Therapy. Brain Sciences 2023;13:426. [DOI: 10.3390/brainsci13030426] [Reference Citation Analysis]
2 Di Bartolomeo M, Stark T, Di Martino S, Iannotti FA, Ruda-Kucerova J, Romano GL, Kuchar M, Laudani S, Palivec P, Piscitelli F, Wotjak CT, Bucolo C, Drago F, Di Marzo V, D'Addario C, Micale V. The Effects of Peripubertal THC Exposure in Neurodevelopmental Rat Models of Psychopathology. Int J Mol Sci 2023;24. [PMID: 36835313 DOI: 10.3390/ijms24043907] [Reference Citation Analysis]
3 Jîtcă G, Ősz BE, Vari CE, Rusz CM, Tero-Vescan A, Pușcaș A. Cannabidiol: Bridge between Antioxidant Effect, Cellular Protection, and Cognitive and Physical Performance. Antioxidants (Basel) 2023;12. [PMID: 36830042 DOI: 10.3390/antiox12020485] [Reference Citation Analysis]
4 Bilecki W, Maćkowiak M. Gene Expression and Epigenetic Regulation in the Prefrontal Cortex of Schizophrenia. Genes (Basel) 2023;14. [PMID: 36833173 DOI: 10.3390/genes14020243] [Reference Citation Analysis]
5 Morén C, Treder N, Martínez-pinteño A, Rodríguez N, Arbelo N, Madero S, Gómez M, Mas S, Gassó P, Parellada E. Systematic Review of the Therapeutic Role of Apoptotic Inhibitors in Neurodegeneration and Their Potential Use in Schizophrenia. Antioxidants 2022;11:2275. [DOI: 10.3390/antiox11112275] [Reference Citation Analysis]